|
Reipert, B.M., Gandadharan, B., Berg, V., Schweiger, H., Scheiflinger, F., Bowen, J., Blatny, J., Fijnvandraat, K., Gruppo, R., Klintman, J., Male, C., McGuinn, C., Meeks, S.L., Radulescu, V.C., Ragni, M.V., Recht, M., Santagostino, E., Shapiro, A.D., Staber, J.M., Yaish, H.M. The prospective hemophilia inhibitor PUP study (HIPS) reveals distinct signatures prior to FVIII inhibitor development. Blood Advances. 2020; 4: 5785-5796.
|